tiprankstipranks
GRI Bio (GRI)
NASDAQ:GRI
US Market

GRI Bio (GRI) Income Statement

88 Followers

GRI Bio Income Statement

Last quarter (Q4 2023), GRI Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, GRI Bio's net income was $-1.89M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---$ 100.00K$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 8.79M$ 6.93M$ -9.26M$ 4.89M$ 3.15M$ 4.31M
Operating Income
$ -11.56M$ -6.93M$ -9.26M$ -4.79M$ -3.15M$ -4.31M
Net Non Operating Interest Income Expense
$ -902.00K$ 26.00K$ -16.00K$ -34.00K$ -197.00K$ 1.06K
Other Income Expense
$ 172.00K$ -384.00K$ 28.00K-$ -113.00K-
Pretax Income
$ -12.62M$ -6.52M$ -9.30M$ -4.82M$ -3.46M$ -4.31M
Tax Provision
--$ 0.00---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -12.61M$ -2.27M$ -9.30M$ -4.82M$ -3.46M$ -4.31M
Basic EPS
$ -8.59$ -0.69$ -1.42$ -0.78$ -0.60$ -0.74
Diluted EPS
$ -8.59$ -0.69$ -1.42$ -0.78$ -0.60$ -0.74
Basic Average Shares
$ 17.14M$ 10.14M$ 6.54M$ 6.76M$ 5.80M$ 5.80M
Diluted Average Shares
$ 17.14M$ 10.14M$ 6.54M$ 6.76M$ 5.80M$ 5.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 8.79M$ 6.93M$ -9.26M$ 4.89M$ 3.15M$ 4.31M
Net Income From Continuing And Discontinued Operation
$ -12.61M$ -2.27M$ -9.30M$ -4.82M$ -3.46M$ -4.31M
Normalized Income
$ -1.87M--$ -4.82M$ -3.35M$ -4.31M
Interest Expense
---$ 34.00K$ 197.00K-
EBIT
$ -12.66M$ -6.52M$ -9.29M$ -4.79M$ -3.27M$ -4.31M
EBITDA
$ -10.52M$ -6.28M$ -9.18M$ -4.71M$ -3.25M$ -4.31M
Currency in USD

GRI Bio Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis